Two Seas Capital LP Reports New 9.99% Stake in PAVmed Inc. (PAVM)

Two Seas Capital LP, along with its general partner Two Seas Capital GP LLC and Managing Member Sina Toussi, filed a Schedule 13G on May 15, 2026, reporting a 9.99% stake in PAVmed Inc. (PAVM). As of the event date of March 31, 2026, the reporting persons collectively beneficially own 657,219 shares of common stock. This position includes 461,539 shares held directly by Two Seas Global (Master) Fund LP and 195,680 shares obtainable through the exercise of warrants within 60 days. The filing indicates that the total warrants held would allow for the purchase of 461,539 shares, but the reported amount is limited by beneficial ownership blockers. The reporting persons have sole voting and dispositive power over the shares. This filing represents a new significant holding for Two Seas Capital LP in PAVmed Inc., as the previous ownership was reported as 0.0%. The shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.